Protagenic Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-1.4M | $-1.4M | — | $888.3K |
| FY2018 | $-1.1M | $-1.1M | — | $1.1M |
| FY2019 | $-488.0K | $-488.0K | — | $797.8K |
| FY2020 | $-1.3M | $-1.3M | — | $1.7M |
| FY2021 | $-2.8M | $-2.8M | — | $1.5M |
| FY2022 | $-2.0M | $-2.0M | $1.8K | $864.7K |
| FY2023 | $-3.7M | $-3.9M | $149.8K | $666.8K |
| FY2024 | $-4.2M | $-4.2M | — | $923.1K |
| FY2025 | $-1.8M | $-1.8M | — | — |
| FY2026 | $-2.8M | $-2.8M | $3.3K | $418.6K |